These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1267204)

  • 21. The lipoic acid containing components of the 2-oxoacid dehydrogenase complexes mimic trifluoroacetylated proteins and are autoantigens associated with halothane hepatitis.
    Frey N; Christen U; Jenö P; Yeaman SJ; Shimomura Y; Kenna JG; Gandolfi AJ; Ranek L; Gut J
    Chem Res Toxicol; 1995; 8(5):736-46. PubMed ID: 7548757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase.
    Martin JL; Kenna JG; Martin BM; Thomassen D; Reed GF; Pohl LR
    Hepatology; 1993 Oct; 18(4):858-63. PubMed ID: 8406360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unexplained hepatitis after podiatric surgery with halothane anesthesia.
    Boyce-Smith G; Scherer PR
    J Am Podiatr Med Assoc; 1985 Jan; 75(1):23-7. PubMed ID: 3981433
    [No Abstract]   [Full Text] [Related]  

  • 24. [Halothane hepatitis].
    Dentan M; Desmonts JM; Berthelot P
    Presse Med (1893); 1971 Jun; 79(28):1285-8. PubMed ID: 5563076
    [No Abstract]   [Full Text] [Related]  

  • 25. Hapten carrier conjugates associated with halothane hepatitis.
    Pohl LR; Thomassen D; Pumford NR; Butler LE; Satoh H; Ferrans VJ; Perrone A; Martin BM; Martin JL
    Adv Exp Med Biol; 1991; 283():111-20. PubMed ID: 2068977
    [No Abstract]   [Full Text] [Related]  

  • 26. [Test of lymphocyte transformation in 2 cases of hepatitis after anesthesia with halothane].
    Mathieu A; Walzer S
    Anesth Analg (Paris); 1973; 30(1):109-16. PubMed ID: 4721988
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of structural alterations in the synthesis of halothane metabolite antigens to mimic halothane-induced immunogen.
    Hubbard AK; Levy JP; Roth TP; Gandolfi AJ
    Drug Chem Toxicol; 1990; 13(2-3):93-112. PubMed ID: 1703476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Halothane in the United States. An appraisal of the literature on "halothane hepatitis" and the American reaction to it.
    Dykes MH; Gilbert JP; McPeek B
    Br J Anaesth; 1972 Sep; 44(9):925-34. PubMed ID: 4564265
    [No Abstract]   [Full Text] [Related]  

  • 29. Unexplained hepatitis following halothane.
    Burns TH
    Anaesthesia; 1987 Jan; 42(1):76. PubMed ID: 3826578
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis of halothane hepatitis.
    Mathiew A
    JAMA; 1973 May; 224(8):1188-9. PubMed ID: 4739876
    [No Abstract]   [Full Text] [Related]  

  • 31. Halothane in Britain today.
    Strunin L; Simpson BR
    Br J Anaesth; 1972 Sep; 44(9):919-24. PubMed ID: 4564264
    [No Abstract]   [Full Text] [Related]  

  • 32. HLA A and B locus antigens in patients with unexplained hepatitis following halothane anaesthesia.
    Eade OE; Grice D; Krawitt EL; Trowell J; Albertini R; Festenstein H; Wright R
    Tissue Antigens; 1981; 17(4):428-32. PubMed ID: 7330846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice.
    Walton B; Dumonde DC; Williams C; Jones D; Strunin JM; Layton JM; Strunin L; Simpson R
    JAMA; 1973 Jul; 225(5):494-8. PubMed ID: 4740337
    [No Abstract]   [Full Text] [Related]  

  • 34. "Halothane hepatitis".
    Hehre FW
    Conn Med; 1974 Jun; 38(6):307-8. PubMed ID: 4831387
    [No Abstract]   [Full Text] [Related]  

  • 35. Halothane hepatitis in a young child.
    Lewis RB; Blair M
    Br J Anaesth; 1982 Mar; 54(3):349-54. PubMed ID: 7066130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity to halothane metabolite-modified proteins in halothane hepatitis.
    Kenna JG; Knight TL; van Pelt FN
    Ann N Y Acad Sci; 1993 Jun; 685():646-61. PubMed ID: 8363272
    [No Abstract]   [Full Text] [Related]  

  • 37. Halothane hepatitis: allergy or idiosyncrasy?
    Dienstag JL
    N Engl J Med; 1980 Jul; 303(2):102-4. PubMed ID: 7383060
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental immunity to a metabolite of halothane and fluroxene: cutaneous delayed-type hypersensitivity.
    Mathieu A; DiPadua D; Mills J; Kahan B
    Anesthesiology; 1974 Apr; 40(4):385-90. PubMed ID: 4150486
    [No Abstract]   [Full Text] [Related]  

  • 39. Halothane hepatitis: toxicity or hypersensitivity?
    Chapman BA; Laurenson VG; Cook HB
    N Z Med J; 1985 Sep; 98(787):793-6. PubMed ID: 3865077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Halothane hepatitis].
    Goldfarb G
    Ann Fr Anesth Reanim; 1982; 1(6):629-33. PubMed ID: 6764338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.